221 related articles for article (PubMed ID: 32680447)
21. Patient Input for Design of a Decision Support Smartphone Application for Type 1 Diabetes.
Wilson LM; Tyler N; Jacobs PG; Gabo V; Senf B; Reddy R; Castle JR
J Diabetes Sci Technol; 2020 Nov; 14(6):1081-1087. PubMed ID: 31441336
[TBL] [Abstract][Full Text] [Related]
22. Characterizing Glycemic Control and Sleep in Adults with Long-Standing Type 1 Diabetes and Hypoglycemia Unawareness Initiating Hybrid Closed Loop Insulin Delivery.
Malone SK; Peleckis AJ; Grunin L; Yu G; Jang S; Weimer J; Lee I; Rickels MR; Goel N
J Diabetes Res; 2021; 2021():6611064. PubMed ID: 33628834
[TBL] [Abstract][Full Text] [Related]
23. Economic Model Predictive Control of Bihormonal Artificial Pancreas System Based on Switching Control and Dynamic R-parameter.
Tang F; Wang Y
J Diabetes Sci Technol; 2017 Nov; 11(6):1112-1123. PubMed ID: 28728434
[TBL] [Abstract][Full Text] [Related]
24. Safety and effectiveness of do-it-yourself artificial pancreas system compared with continuous subcutaneous insulin infusions in combination with free style libre in people with type 1 diabetes.
Patel R; Crabtree TSJ; Taylor N; Langeland L; Gazis AT; Mendis B; Wilmot EG; Idris I
Diabet Med; 2022 May; 39(5):e14793. PubMed ID: 35034388
[TBL] [Abstract][Full Text] [Related]
25. Automatic data processing to achieve a safe telemedical artificial pancreas.
Hernando ME; García-Sáez G; Martínez-Sarriegui I; Rodríguez-Herrero A; Pérez-Gandía C; Rigla M; de Leiva A; Capel I; Pons B; Gómez EJ
J Diabetes Sci Technol; 2009 Sep; 3(5):1039-46. PubMed ID: 20144417
[TBL] [Abstract][Full Text] [Related]
26. Effect of predicted low suspend pump treatment on improving glycaemic control and quality of sleep in children with type 1 diabetes and their caregivers: the QUEST randomized crossover study.
Schierloh U; Aguayo GA; Fichelle M; De Melo Dias C; Celebic A; Vaillant M; Barnard K; Cohen O; de Beaufort C
Trials; 2018 Dec; 19(1):665. PubMed ID: 30509293
[TBL] [Abstract][Full Text] [Related]
27. Evolution of Do-It-Yourself Remote Monitoring Technology for Type 1 Diabetes.
Ng M; Borst E; Garrity A; Hirschfeld E; Lee J
J Diabetes Sci Technol; 2020 Sep; 14(5):854-859. PubMed ID: 31893941
[TBL] [Abstract][Full Text] [Related]
28. Multicenter user evaluation of ACCU-CHEK® Combo, an integrated system for continuous subcutaneous insulin infusion.
Kerr D; Hoogma RP; Buhr A; Petersen B; Storms FE;
J Diabetes Sci Technol; 2010 Nov; 4(6):1400-7. PubMed ID: 21129336
[TBL] [Abstract][Full Text] [Related]
29. Patient-Driven Diabetes Technologies: Sentiment and Personas of the #WeAreNotWaiting and #OpenAPS Movements.
Litchman ML; Walker HR; Fitzgerald C; Gomez Hoyos M; Lewis D; Gee PM
J Diabetes Sci Technol; 2020 Nov; 14(6):990-999. PubMed ID: 32627587
[TBL] [Abstract][Full Text] [Related]
30. Impact on Diabetes Self-Management and Glycemic Control of a New Color-Based SMBG Meter.
Schnell O; Klausmann G; Gutschek B; Garcia-Verdugo RM; Hummel M
J Diabetes Sci Technol; 2017 Nov; 11(6):1218-1225. PubMed ID: 28443343
[TBL] [Abstract][Full Text] [Related]
31. Are We Ready to Treat Our Diabetes Patients Using Social Media? Yes, We Are.
Petrovski G; Zivkovic M
J Diabetes Sci Technol; 2019 Mar; 13(2):171-175. PubMed ID: 30132685
[TBL] [Abstract][Full Text] [Related]
32. Type 1 diabetes mellitus management in young children: implementation of current technologies.
Nevo-Shenker M; Phillip M; Nimri R; Shalitin S
Pediatr Res; 2020 Mar; 87(4):624-629. PubMed ID: 31715623
[TBL] [Abstract][Full Text] [Related]
33. Control to range for diabetes: functionality and modular architecture.
Kovatchev B; Patek S; Dassau E; Doyle FJ; Magni L; De Nicolao G; Cobelli C;
J Diabetes Sci Technol; 2009 Sep; 3(5):1058-65. PubMed ID: 20144419
[TBL] [Abstract][Full Text] [Related]
34. Impact of Custom Features of Do-it-yourself Artificial Pancreas Systems (DIYAPS) on Glycemic Outcomes of People with Type 1 Diabetes.
Staszak W; Chromik J; Braune K; Arnrich B
Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():1472-1475. PubMed ID: 34891563
[TBL] [Abstract][Full Text] [Related]
35. Appearance of Do-It-Yourself closed-loop systems to manage type 1 diabetes.
Hng TM; Burren D
Intern Med J; 2018 Nov; 48(11):1400-1404. PubMed ID: 30387315
[TBL] [Abstract][Full Text] [Related]
36. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
[TBL] [Abstract][Full Text] [Related]
37. Fluctuations of Hyperglycemia and Insulin Sensitivity Are Linked to Menstrual Cycle Phases in Women With T1D.
Brown SA; Jiang B; McElwee-Malloy M; Wakeman C; Breton MD
J Diabetes Sci Technol; 2015 Oct; 9(6):1192-9. PubMed ID: 26468135
[TBL] [Abstract][Full Text] [Related]
38. From Multiple Daily Injections to Hybrid Closed-Loop System in Ten Days, Utilizing a Structured Initiation Protocol.
Petrovski G; Al Khalaf F; Campbell J; Fisher H; Umer F; Hussain K
J Diabetes Sci Technol; 2020 May; 14(3):689-690. PubMed ID: 31876178
[No Abstract] [Full Text] [Related]
39. Stress Testing of an Artificial Pancreas System With Pizza and Exercise Leads to Improvements in the System's Fuzzy Logic Controller.
Mauseth R; Lord SM; Hirsch IB; Kircher RC; Matheson DP; Greenbaum CJ
J Diabetes Sci Technol; 2015 Sep; 9(6):1253-9. PubMed ID: 26370244
[TBL] [Abstract][Full Text] [Related]
40. Stochastic Seasonal Models for Glucose Prediction in the Artificial Pancreas.
Montaser E; Díez JL; Bondia J
J Diabetes Sci Technol; 2017 Nov; 11(6):1124-1131. PubMed ID: 29039207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
